AmerisourceBergen completed the acquisition of Walgreens' Alliance Healthcare businesses for $6.5bn.

AmerisourceBergen, an American drug wholesale company, completed the acquisition of Alliance Healthcare, a wholesaler, distributor, and retailer of pharmaceutical, surgical, medical, and healthcare products, from Walgreens Boots Alliance, an American holding company, for $6.5bn, comprised of c. $6.3bn in cash and 2m shares of AmerisourceBergen common stock. “This strategic agreement with AmerisourceBergen, which we consider to be the world’s leading pharmaceutical wholesaler, is a very positive development for the two companies. This deal will enable significant value creation for both companies and will generate new synergies in addition to those already captured. It is a logical step following the success of our long-term strategic relationship with AmerisourceBergen which has been a strong and trusted partner since 2013. The transaction will fuel higher future investments to grow and transform our core retail pharmacy and healthcare businesses, and is EPS accretive long-term for Walgreens Boots Alliance,” Stefano Pessina, Walgreens Boots Alliance Executive Vice Chairman and CEO.